Free Newsletter
Eli Lilly to outsource half of research by 2010
Free newsletter via e-mail
Tools
While other big pharma companies have been making headlines with big layoffs and global restructuring plans, Eli Lilly has been steadily chipping away at its own strategy--quietly outsourcing jobs and services for research and manufacturing around the world as it gradually lowers its head count. About 40 percent of its IT work has already been outsourced with outside partners expected to handle half of its research work by 2010.
- read the report on Lilly's plans from the Indianapolis Star
Related Articles:
Lilly developing biotech drugs the old-fashioned way. Report
Lilly declares a truce in diabetes rep war. Report
Top Lilly exec plays secret sales agent. Report
Lilly predicts double-digit earnings growth. Report
Comments
By Anonymous | Posted 1:18pm | October 8, 2008
I think you should have said Lilly is chipping away small biotech companies, buying them up and deleting them, insidiously outsourcing jobs to India and China and leaving a wake of unemployed scientists who dedicated their adult lives to training in Science (8-10 years of college). I'd like to see a big Pharma company reinvent a way to employ US Scientists and make the finances work. I also believe they will get what they pay for and this strategy will backfire. Treating employees like disposables is going to cause the well to run dry and the ideas that Big Pharma regularly scoop up from little biotech will dry up with them. That is Karma.
Click here to get the FierceBiotech email newsletter for FREE!
Comments (1) | Post a comment